内皮微波消融与内皮激光消融治疗慢性大隐静脉功能不全所致静脉曲张的疗效与安全性:一项Meta分析
该Meta分析纳入2项随机对照试验和1项队列研究,比较内皮微波消融(EMA)与内皮激光消融(EVLA)治疗慢性大隐静脉功能不全所致静脉曲张。EMA手术时间显著短于EVLA(均数差-6.62分钟,95%CI -11.91至-1.32,P=0.01),疗效指标相似,瘀斑发生率EMA组显著低于EVLA组(OR 0.58)。作者认为EMA可能缩短手术时间并可能降低操作风险,疗效与EVLA相当,仍需延长随访(超过12个月)和标准化方法学的进一步研究。
要点
- EMA手术时间显著短于EVLA(均数差-6.62分钟,95%CI -11.91至-1.32,P=0.01),但异质性高。
- EMA与EVLA在阿伯丁生活质量评分、视觉模拟评分、住院时间和6个月再通率方面疗效相似。
- EMA组瘀斑发生率显著低于EVLA组(OR 0.58),其他安全性指标相似。
核心结论
- EMA可能缩短手术时间并可能降低操作风险,在治疗慢性大隐静脉功能不全所致静脉曲张方面疗效与EVLA相当。
- 仍需开展随访时间超过12个月且方法学标准化的研究来比较这两种技术。
研究设计与样本
- 检索PubMed、Scopus、Science Direct和Cochrane Library截至2024年11月11日的随机对照试验和队列研究。
- 共纳入2项随机对照试验和1项队列研究。
- 随机对照试验使用Cochrane偏倚风险工具评估偏倚风险,队列研究使用纽卡斯尔-渥太华量表评估。
- 使用Review Manager 5.4.0进行Meta分析,采用逆方差随机效应模型,并进行Duval and Tweedie剪补法敏感性分析。
主要发现
- 在治疗大隐静脉静脉曲张方面,EMA手术时间显著短于EVLA(均数差-6.62分钟,95%CI -11.91至-1.32,P=0.01),但异质性高。
- EMA与EVLA在阿伯丁生活质量评分、视觉模拟评分、住院时间和6个月再通率方面疗效相似。
- 安全性方面,EMA组瘀斑发生率显著低于EVLA组(OR 0.58),其他安全性指标相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- EMA与EVLA手术时间比较的异质性高。
- 仍需开展随访时间超过12个月且方法学标准化的研究来比较这两种技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although guidelines have established endovenous laser ablation (EVLA) as the first-line option for patients with varicose veins (VVs) in chronic great saphenous vein (GSV) insufficiency; however, chronic vein insufficiency remains a significant health-care burden. Endovenous microwave ablation (EMA) is a promising alternative. This review aims to analyze EMA versus EVLA for VVs in chronic GSV insufficiency. METHODS: Randomized controlled trials (RCTs) and cohort studies across PubMed, Scopus, Science Direct, and the Cochrane Library up to November 11, 2024 were searched. Risk of bias was evaluated using the Cochrane Risk of Bias Tool for RCT and Newcastle-Ottawa Scale for Cohort studies. Meta-analysis was done using Review Manager 5.4.0 using an inverse variance random-effects model with Duval and Tweedie trim-and-fill sensitivity analysis. RESULTS: Overall, a total of 2 RCTs and 1 cohort study included. In treating GSV VVs, EMA has proven to have shorter duration of operation significantly compared to EVLA (mean difference: -6.62 [95% confidence interval: -11.91 to -1.32, P = 0.01]) although heterogeneity is high. EMAs have similar profiles in efficacy compared to EVLA (Aberdeen score of quality of life, visual analog scale score, length of hospital stays, and recanalization rate in 6 months). In terms of safety, the incidence of ecchymosis was found to be lower in the EMA group compared to the EVLA group significantly (odds ratio: 0.58). Other safety profiles were found to be similar. CONCLUSION: EMA might lower operating time, potentially reducing procedure risks, and is equally effective as EVLA in treating VVs in chronic GSV insufficiency. Further research comparing these techniques with extended follow-up periods (over 12 months) and standardized study methodologies are still needed.
引用
- Kalaij AGI, Zahrani S, Saputro KB, et al. Efficacy and Safety of Endovenous Microwave Ablation Versus Endovenous Laser Ablation for Varicose Veins in Chronic Great Saphenous Vein Insufficiency: A Meta-Analysis. Ann Vasc Surg. 2025. PMID: 39863274. doi:10.1016/j.avsg.2024.12.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。